Submitted by Anonymous (not verified) on 12 January 2026 - 12:54
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 36, Status: Authorised
Source: